Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATRIUM: Abatacept in ICI Myocarditis
NCT05335928Phase 3Recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2022
- Primary completion
- Apr 2029
- Modality
- Fc-Fusion Proteins
- Countries
- 2
01
Overview
A Phase 3 trial of abatacept in myocarditis, sponsored by Massachusetts General Hospital. Started Jul 2022; status: recruiting.
02
Drugs
abatacept
03
Conditions
myocarditis
Beyond the preview
Go deeper on NCT05335928.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05335928.